Login / Signup

Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS). Reply.

Kathleen W ZhangAvirup Guha
Published in: The Journal of urology (2021)
Keyphrases
  • cardiovascular events
  • prostate cancer
  • coronary artery disease
  • cardiovascular disease
  • adverse drug
  • radical prostatectomy
  • middle aged
  • stem cells
  • type diabetes
  • drug induced